Skip to main content

InnovAge Holding Corp.

corporate_fare Company Profile

InnovAge Holding Corp.

INNV·NASDAQ·Industrial Applications And Services·CIK 0001834376

InnovAge Holding Corp. is a leading healthcare delivery platform that provides all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. The company's programs aim to improve the quality of care for participants, enable them to remain in their homes safely for as long as possible, and reduce the use of expensive care settings like hospitals and nursing homes. Through its Program of All-Inclusive Care for the Elderly ("PACE"), InnovAge offers a wide range of medical and ancillary services. These include in-home care services (skilled, unskilled, and personal care), in-center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities. InnovAge also provides transportation to and from PACE centers and third-party medical appointments, as well as care management. The company contracts directly with government payors like Medicare and Medicaid, without relying on third-party administrative organizations or health plans. InnovAge Holding Corp. and certain wholly owned subsidiaries were formed as for-profit corporations on May 13, 2016, to acquire Total Community Options, Inc. d/b/a InnovAge, which was established in May 2007. Total Community Options, Inc. and some of its subsidiaries converted from not-for-profit to for-profit corporations during this purchase. In March 2021, coinciding with its initial public offering ("IPO"), the company changed its name from TCO Group Holdings, Inc. to InnovAge Holding Corp.

InnovAge Holding Corp. (NASDAQ:INNV) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for INNV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for INNV spans 10-Q, 8-K, 424B7, 10-K.

Recent high-impact activity:

  • InnovAge Puts DOJ False Claims Act Case Behind It With Civil Settlement
  • InnovAge Q1 FY27: Net Income Triples to $20.9M; DOJ Settlement Paid, Derivative Deal Collapses
  • InnovAge Q1 FY2027: Revenue Up 12.1% to $264.8M, Net Income Triples to $20.9M
  • Q1 Revenue Up 12% to $264.8M, Net Income Nearly Triples to $20.9M
  • Apax/WCAS Funds Price 10M InnovAge Share Sale at $9.25

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$989.71M
Net Income
-$2.54M
Diluted EPS
-$0.02
Op. Cash Flow
$64.71M
Free Cash Flow
$50.41M
Gross Profit
$227.76M
Operating Income
$2.62M
Cash & Equivalents
$97.89M
Total Debt
$48.06M
Debt / Equity
0.20×
Net Margin
-0.3%
Shares Outstanding
136.02M sh
Source: 10-K · filed 2026-09-08 · accession 0001834376-26-000049

Short Interest & Short Volume

1.44 days to cover

FINRA reported short interest of 893,173 shares in INNV as of the October 30, 2026 settlement, a 22.1% decrease from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 42.6% of INNV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)893,173 shares as of October 30, 2026
Change vs prior period▼ 22.1%
Days to cover1.44 at avg daily volume of 618,230
Daily short volume (FINRA facilities)42.6% of 204,494 shares on November 20, 2026
5-day average short volume54.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for INNV, detected from its recent SEC filings · based on capital-structure filings through 2026-09-23.

1 recent capital raise1 shelf registration

Secondary Offering Finalized · Controlling Stake Reduced

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with I →
$9.16
52-week range · as of 2026-11-03 $3.94 – $12.64
Market cap
$1.25B
Volume
498.4K (0.9× avg)
3-mo avg 540.2K
Live data · 2026-11-21 21:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INNV - Latest Insights

INNV
Nov 18, 2026, 4:09 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $9.16 info
Change: +$0.250 (+3%) info
Market Cap: $1.25B info
INNV
Nov 03, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.16 info
Change: +$0.310 (+4%) info
Market Cap: $1.25B info
INNV
Nov 03, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.16 info
Change: +$0.310 (+4%) info
Market Cap: $1.25B info
INNV
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.16 info
Change: +$0.310 (+4%) info
Market Cap: $1.25B info
INNV
Sep 23, 2026, 2:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.16 info
Change: -$0.490 (-5%) info
Market Cap: $1.25B info
INNV
Sep 22, 2026, 5:19 PM EDT
Filing Type: 424B7
Importance Score:
7
Price at Filing: $9.51
Real-time Price: $9.16 info
Change: -$0.350 (-4%) info
Market Cap: $1.25B info
INNV
Sep 22, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $10.10
Real-time Price: $9.16 info
Change: -$0.940 (-9%) info
Market Cap: $1.25B info
INNV
Sep 08, 2026, 7:21 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $11.91
Real-time Price: $9.16 info
Change: -$2.75 (-23%) info
Market Cap: $1.25B info
INNV
Sep 08, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.56
Real-time Price: $9.16 info
Change: -$2.40 (-21%) info
Market Cap: $1.25B info
INNV
Sep 08, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.51
Real-time Price: $9.16 info
Change: -$2.35 (-20%) info
Market Cap: $1.25B info
INNV
Jul 31, 2026, 4:11 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $11.36
Real-time Price: $9.16 info
Change: -$2.20 (-19%) info
Market Cap: $1.25B info
INNV
May 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.56
Real-time Price: $9.16 info
Change: +$1.60 (+21%) info
Market Cap: $1.25B info
INNV
May 07, 2026, 7:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.08
Real-time Price: $9.16 info
Change: +$1.08 (+13%) info
Market Cap: $1.25B info
INNV
May 05, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.55
Real-time Price: $9.16 info
Change: +$0.610 (+7%) info
Market Cap: $1.25B info
INNV
May 05, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.30
Real-time Price: $9.16 info
Change: +$0.860 (+10%) info
Market Cap: $1.25B info
INNV
Feb 03, 2026, 5:09 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.72
Real-time Price: $9.16 info
Change: +$3.44 (+60%) info
Market Cap: $1.25B info
INNV
Feb 03, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.66
Real-time Price: $9.16 info
Change: +$3.50 (+62%) info
Market Cap: $1.25B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets